Temazepam Capsule
Product Images NDC 50268-779

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Temazepam (NDC 50268-779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (779 15)

FDA Label Image

1 (780 13)

FDA Label Image

Temazepam (Temazepam Header)

Temazepam (Temazepam Header)
Temazepam Capsules, USP are a medication containing the active ingredient temazepam. They are commonly used for the treatment of insomnia and other sleep disorders. Temazepam is a sedative-hypnotic drug that helps to promote relaxation and induce sleep. It belongs to the class of benzodiazepines and works by enhancing the effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain. These capsules are available in various strengths and are typically taken orally before bedtime. It is important to follow the prescribed dosage and instructions provided by a healthcare professional. Common side effects may include drowsiness, dizziness, and headache. It is recommended to use temazepam under medical supervision and not exceed the prescribed dose.*
FDA Label Image

Temazepam-str (Temazepam Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.